Press ReleaseWePlay App 4th Anniversary Carnival: A Grand Social Gathering Where Play Brings Friends Together! TAIPEI, April 2, 2025 /PRNewswire/ — As a renowned app blending casual… CISION PRNewswireApril 2, 2025
CNOOC Limited Subsidiary Completed the Transaction with INEOS Energy HONG KONG, April 2, 2025 /PRNewswire/ — CNOOC Limited (the "Company", SEHK:… CISION PRNewswireApril 2, 2025
Press ReleaseSino Inno Lab and the Spark Promote I&T Integration in Daily Life Engaging Over 2,000 Individuals in Its First Year in the Northern Metropolis… CISION PRNewswireApril 2, 2025
Veda KM (CSRone) Recognized as Best Sustainability Advisory Firm by Acquisition International in UK, Creating Corporate Value with Collaborative Counseling! TAIPEI, April 2, 2025 /PRNewswire/ — Veda KM (CSRone), Veda International Group’s… CISION PRNewswireApril 2, 2025
Data4Life releases Data2Evidence as open source: a new chapter for global health research POTSDAM, Germany, April 2, 2025 /PRNewswire/ — Data4Life, the nonprofit digital health… CISION PRNewswireApril 2, 2025
Press ReleaseOne Bangkok Drenches the City in Songkran Joy: "One Bangkok, One Lagoon Splashing Songkran Rhythms" – The Ultimate Songkran Celebration for Everyone BANGKOK, April 2, 2025 /PRNewswire/ — One Bangkok invites everyone to immerse… CISION PRNewswireApril 2, 2025
Senhwa Biosciences Announces Positive Clinical Data from Phase 1/Expansion Trial of Silmitasertib (CX-4945) in the Treatment of Basal Cell Carcinoma Basal Cell Carcinoma CSR Highlights CX-4945 Monotherapy: Progression-free survival (PFS) exceeded 21 months… CISION PRNewswireApril 2, 2025
Over 2/3 of Companies Surveyed Believe that Reciprocal Tariffs Present Greater Concerns for Business Survey by The American Chamber of Commerce in Singapore (AmChamSG) Reveals a… CISION PRNewswireApril 2, 2025
